Apoptotic effect of thymoquinone on OVCAR3 cells via the P53 and CASP3 activation

Özge Karaosmanoğlu1, Zeynep Kamalak2, İlhan Özdemir3

  • 1Acibadem Maslak Hospital, IVF Clinic - Istanbul - Turkey.

Acta Cirurgica Brasileira
|November 13, 2024
PubMed
Abstract

Insights

Thymoquinone effectively reduced ovarian cancer cell viability and increased apoptotic gene expression (p53 and Caspase-3). This suggests thymoquinone is a promising therapeutic agent for ovarian cancer treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Classical cancer treatments have limitations.
  • Novel therapeutic agents are needed for effective cancer treatment.
  • Thymoquinone exhibits diverse biological activities.

Purpose of the Study:

  • To investigate the cytotoxic effects of thymoquinone on ovarian cancer cells.
  • To analyze the impact of thymoquinone on apoptotic gene expression (p53 and Caspase-3) in ovarian cancer.
  • To evaluate thymoquinone as a potential therapeutic agent for ovarian cancer.

Main Methods:

  • Ovarian adenocarcinoma cells (OVCAR3) were treated with varying concentrations of thymoquinone over different time periods.
  • Cell viability was assessed using the MTT assay.
  • Quantitative real-time polymerase chain reaction (qRT-PCR) was employed to analyze the expression levels of p53 and Caspase-3 genes.

Main Results:

  • Thymoquinone demonstrated a significant dose- and time-dependent reduction in OVCAR3 cell viability (p < 0.05).
  • The expression of both Caspase-3 and p53 genes was found to increase in OVCAR3 cells treated with thymoquinone.
  • These findings indicate thymoquinone's cytotoxic and pro-apoptotic effects on ovarian cancer cells.

Conclusions:

  • Thymoquinone exhibits significant in-vitro cytotoxic activity against ovarian cancer cells.
  • The observed increase in apoptotic gene expression supports thymoquinone's role in inducing apoptosis.
  • Thymoquinone is a promising agent for future ovarian cancer treatment, warranting further comprehensive studies for potential clinical application.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
3.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K